Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 30 Jun 2021
Sanofi’s Praluent provides solution for Korean dyslipidaemia patients
30 June 2021 - Sanofi Aventis is strengthening its position in the local dyslipidaemia treatment market with Praluent (alirocumab), a ...
Posted by Michael Wonder on 30 Jun 2021
Schedule of Pharmaceutical Benefits - 1 July 2021
1 July 2021 - The July 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in ...
Posted by Michael Wonder on 30 Jun 2021
Allogene Therapeutics granted FDA fast track designation for ALLO-605, the first TurboCAR T Cell therapy, for the treatment of relapsed/refractory multiple myeloma
30 June 2021 - TurboCAR technology provides selective, programmable cytokine signaling designed to improve function and potency of AlloCAR T cells. ...
Posted by Michael Wonder on 30 Jun 2021
Eli Lilly CEO says drug maker will keep looking for ways to cut insulin costs as Walmart debuts lower price rival
29 June 2021 - Insulin has become a focal point in lawmakers’ debate over soaring drug prices — especially since it ...
Posted by Michael Wonder on 30 Jun 2021
In revised evidence report, ICER confirms judgment that evidence is insufficient to demonstrate net health benefit of aducanumab for patients with Alzheimer’s disease
30 June 2021 - Accepting the uncertainty associated with the positive estimate obtained from pooled data from both pivotal trials, ...
Posted by Michael Wonder on 30 Jun 2021
States step up push to regulate pharmacy drug brokers
30 June 2021 - Under pressure to rein in skyrocketing prescription drug costs, states are targeting companies that serve as conduits ...
Posted by Michael Wonder on 30 Jun 2021
Nurse prescribers now able to initiate Special Authority medicines
30 June 2021 - Joint media release with the Ministry of Health ...
Posted by Michael Wonder on 30 Jun 2021
European Commission approves Merck’s Keytruda (pembrolizumab) plus chemotherapy for certain patients with oesophageal cancer or HER2 negative gastro-oesophageal junction adenocarcinoma
29 June 2021 - Keytruda is first anti-PD-1 therapy approved in Europe in combination with chemotherapy for first-line treatment of ...
Posted by Michael Wonder on 30 Jun 2021
Canada again delays overhaul to patented medicine pricing system
29 June 2021 - Health Minister Patty Hajdu is delaying the first big overhaul of Canada’s patented medicines pricing system ...
Posted by Michael Wonder on 30 Jun 2021
Médunik Canada once again receives Notice of Compliance from Health Canada for Ruzurgi (amifampridine) following review ordered by court ruling
29 June 2021 - Médunik Canada is pleased to announce that Health Canada has reissued the approval (Notice of Compliance) ...
Posted by Michael Wonder on 30 Jun 2021
Cend Therapeutics’ CEND-1 granted fast track designation for pancreatic cancer
29 June 2021 - The US FDA has granted fast track development status for Cend’s investigational drug, CEND-1, for the ...
Posted by Michael Wonder on 30 Jun 2021
FDA grants fast track designation to CNS Pharmaceuticals for berubicin for the treatment of recurrent glioblastoma multiforme
29 June 2021 - FDA fast track designation for berubicin highlights the serious unmet medical need for new treatments for glioblastoma ...
Posted by Michael Wonder on 29 Jun 2021
New cancer gene test: are you eligible?
29 June 2021 - In a world first, young Australians will be offered a genetic test to discover whether they carry ...
Posted by Michael Wonder on 29 Jun 2021
Costly new Alzheimer’s drug could force Medicare to restrict access
28 June 2021 - The federal health insurance program may limit who can get the drug, which Biogen priced at $56,000 ...
Posted by Michael Wonder on 29 Jun 2021
Biden won’t end cancer — or any other disease — by importing drug price controls from Europe
28 June 2021 - In his first budget, President Biden set aggressive health goals. “Let’s end cancer as we know ...